Some drugs prescribed (usually) by hospital consultants require regular monitoring
normally via a blood test or other test sample. The frequency of these tests varies dependent on the particular drug being prescribed. Normally, these drugs are initiated by a secondary care consultant and monitoring tests are completed in their clinics. However, when patients are passed back by their consultant into the care of their GP, it is the GP who becomes responsible for the monitoring process.
We have systems in place in the surgery to ensure, as far as possible, that monitoring tests are completed at the appropriate time. However, we have found that some patients do ’slip through the net’ and tests have not been completed as regularly as advised in the guidelines. Where this is the case it may not be possible to reissue a full 28 day supply of a drug until tests have been completed and the results reviewed.
We urge patients who have been placed on one of the drugs requiring regular monitoring to make themselves aware of the specific test regime for the drugs that they are on. Patients should call the surgery if they feel that their tests have not been completed when expected—whether they are under care of their consultant or their GP.